Astaxanthin is a naturally occurring carotenoid in a wide variety of living organisms such as salmon, shrimp, crab, and red snapper. Approximately 90% of the astaxanthin in krill is found in the eye. Asthenopia, or eye fatigue, is an ophthalmological condition with nonspecific symptoms such as eye pain, eye strain, blurred vision, headache, and shoulder stiffness. Symptoms often occur after reading, computer work, or other activities that involve visual display terminals (VDT). More recently, the advances of information technology (IT), software, and electronics have led to the widespread and habitual use of VDT resulting in higher visual fatigue complains and more sufferers. There is, however, no effective therapeutic approach to date. Eye fatigue is usually caused by straining the ciliary body, the eye muscle responsible for accommodation. We previously reported a randomized double-blind placebo controlled study using VDT workers (n=25 treated vs. 23 placebo). 6mg/day astaxanthin supplementation for 4-weeks significantly improved eye fatigue measuring ocular accommodation by the objective instrument and subjective individual assessment. Here we report further 4 clinical studies with the different measurements and an animal study. The same source of astaxanthin, extract derived from the microalgae Haematococcus pluvialis, was used for all of the studies. The first clinical study was performed under randomized double-blind placebo controlled cross-over conditions using 10 healthy subjects. After a 20-minute near visual task, accommodation contraction and relaxation times were extended in both the astaxanthin and placebo groups. However, accommodation relaxation time in the placebo was significantly longer than in the astaxanthin group, and accommodative contraction and relaxation times after a 10-minute rest in the placebo were also significantly longer those in the astaxanthin group. In the second study, the effects of astaxanthin on accommodative recovery derived from a rest after VDT work were studied using 10 healthy volunteers. 6mg/day astaxanthin supplementation for 2-weeks led to a significant relief in accommodative fatigue induced by 30-minutes of IT work (Nintendo Game Boy). In the third study, 22 middle-aged and elder subjects (mean age: 53.9 years) with complaints of eye strain received 6mg/day astaxanthin. Results showed that the pupillary constriction ratio at week 4 was significantly increased compared to that at week 0. The forth clinical study, using 10 healthy subjects, was performed to investigate the effects of visual fatigue on reaction times. Visual fatigue significantly increases reaction time; however 6 mg/day astaxanthin supplementation for 4-weeks was shown to significantly decrease reaction time. We also investigated the intraocular pharmacokinetics of astaxanthin in an albino rabbit. After 100mg/kg astaxanthin administration in a single dose, astaxanthin was detected in the ciliary body as well as the serum at Tmax of 24h and 9h and Cmax of 79.3ng/g and 61.3ng/ml, respectively. Based on the studies it is suggested that astaxanthin supplementation might be a practical and beneficial approach for eye fatigue relief.